Lantern Pharma LTRN
NASDAQ LTRN
$0.57 +0.04 (+6.75%)
At close: Nov 6, 2026 · 4:00 PM EST

Lantern Pharma (LTRN) Debt Ratio (2020)

Updated

Lantern Pharma's (LTRN) Debt Ratio was 0.00 for Q2 2020.

Analysis

Lantern Pharma (LTRN) Debt Ratio (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 0.33
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 0.23
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 0.55
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 0.41
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -0.10
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 0.56
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 0.51
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 0.31
10 Lantern Pharma 7.18 Mn -28.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 0.00
API Access

Lantern Pharma Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=LTRN&period=max&api_key=YOUR_API_KEY